Duncan McVean, Ph.D., is a self-employed consultant specializing in manufacturing, pharmaceutics, and quality control as applied to pharmaceuticals. Most recently, he was CEO of Ridgeway BioSciences, a business spin-off of CCFI. At the same time, he was Chairman of the Board of Scanlabs, a health and wellness company of which he was one of the founders. Prior to that, Dr. McVean was employed by Ben Venue Laboratories as Vice President from September 1984 to October 1999. Previously, he had been employed at Merrell-National Laboratories in Product Development and, later, in Quality Control. His final position at Merrell was Director of Quality Control. He left Merrell National Laboratories to become a co-founder of Gentek, Inc, a manufacturer of generic pharmaceuticals. At Gentek, he was responsible for Product Development and for Manufacturing. He next joined Adria Laboratories, Inc. as Manager of Product Development and shortly thereafter became Director of Manufacturing. He earned a B.S. in Pharmacy, an M.S. in Pharmacy, and a Ph.D. in Pharmaceutical Chemistry (Physical) from the University of Michigan , and, later, an MBA (Humanistic Management) from Xavier University of Cincinnati. He is a Registered Pharmacist in Michigan and Ohio.